Search for: "No. 337" Results 2541 - 2560 of 4,432
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 May 2011, 8:51 pm by Lawrence B. Ebert
The conclusion:Based on the foregoing, this court finds that the Commission provided a sufficient basis for finding no section 337 violation and its actions were not arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with law. [read post]
23 May 2011, 6:14 pm by Phil
Court of Appeals for the Federal Circuit affirmed-in-part, and vacated-in-part, the ITC's final determination in the action brought by Tessera, Inc. against certain DRAM manufacturers, Investigation No. 337-TA-630 ("DRAM ITC action"). [read post]
23 May 2011, 5:15 am by Susan Brenner
Vaughn, 306 Minn. 337, 237 N.W.2d 365 (Minnesota Supreme Court 1976)). [read post]
23 May 2011, 2:20 am by Kelly
Advising inventors, their spouses, and their start-up companies: James Joyce v Armstrong Teasdale (Patently-O) District Court N D California: Use of patent reexamination evidence in parallel litigation: Volterra Semiconductor Corporation v Primarion Inc (Patents Post-Grant) District Court E D California: Government’s approval of false marking settlement precludes later challenge that settlement was “staged” and therefore lacks preclusive effect: Champion Laboratories, Inc v… [read post]
22 May 2011, 6:24 pm by Richard Posner
  Yet the National Institutes of Health expect this year to spend only $18 million on dementia research, $154 million on Parkinson’s research, and $337 milliion on stroke research, compared to more than $8 billion on cancer, heart disease, and diabetes research, even though the diabetes “epidemic,” while real, is due largely to obesity and bad diet. [read post]
20 May 2011, 2:56 pm by Alex Gasser
On May 18, 2011, MOSAID Technologies Inc. of Ottawa, Canada (“MOSAID”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
20 May 2011, 4:59 am by Marie Louise
(EDTexweblog.com)   US Patents – Lawsuits and strategic steps Apple – ALJ Rogers issues initial determination in Certain Digital Imaging Devices and Related Software (337-TA-717) (ITC Law Blog) Apple – Apple, Nike motion to stay denied by Judge Wilken (WHDA) HTC – ALJ Bullock rules on motion to supplement notice of prior art in Certain Portable Electronic Devices and Related Software (337-TA-721) (ITC Law Blog) Lodsys – Patent troll shakes down… [read post]
18 May 2011, 7:10 pm by Eric Schweibenz
(“CSP”) of Auburn, Alabama filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
18 May 2011, 6:58 pm by Alex Gasser
(“Lutron”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
18 May 2011, 5:47 am by David Hart QC
Art. 10(a) of the 85/337 EIA Directive – deriving from the Aarhus Convention -  requires Member States to afford members of the public and NGOs the right to challenge planning decisions as long as the claimant has a “sufficient interest” or maintains “the impairment of a right”, and Member States can choose between these alternatives when implementing the Directive. [read post]
18 May 2011, 3:40 am by tracey
Bund für Umwelt und Naturschutz Deutschland, Landesverband Nordrhein Westfalen eV v Bezirksregierung Arnsberg, Trianel Kohlekraftwerk Lünen GmbH & Co KG, intervening (Case C-115/09);  [2011] WLR (D)  160 “A member state was precluded under article 10a of Directive 85/337/EEC from withholding, from a non-governmental organisation promoting environmental protection, the right to rely before a national court on the infringement of a rule flowing… [read post]
18 May 2011, 12:33 am by Marie Louise
Sun Pharmaceuticals on question of obviousness-type double patenting (Patent Docs) (IPBiz) Glumetza (Metformin) – US: Depomed receives notice of Para IV certification against patents from second ANDA filer, Sun Pharmaceutical (GenericsWeb) Myfortic7 (Mycophenolate) – US: Novartis files patent infringement complaint against Teva in response to Para IV certification filing (Patent Docs) NuvaRing (Etonogestrel, Estradiol) – US: ALJ Luckern sets procedural schedule in Certain Vaginal… [read post]